Worry about weight loss? Study finds THIS obesity drug to help you In an international phase 3a clinical trial, adolescents with obesity who received once-weekly semaglutide compared to placebo had a 16.1percentt decrease in their body mass index (BMI) while the BMI of those who took placebo rose by 0.6 percent.